Time is not on a neurologist's side

At the core of Neuronics Medical is every physician's race against the clock during emergencies requiring immediate intervention. No other clinicians understand better than neurologists that "time is brain". When a stroke occurs, every minute lost results in brain cells lost. Medical intervention just one minute earlier can save 1.9 million brain cells.

When medical experience meets AI's superpower

All our efforts are focused on developing smart, accurate, and, most importantly, timely technology for early stroke detection. Our goal is to shorten the time between stroke occurrence and medical intervention.

By assembling a team of top AI and IT experts to train the algorithm, and partnering with world-renowned vascular neurologists, Neuronics Medical is advancing toward creating the most comprehensive model for automated detection of stroke symptoms.

Dr. Radoslav Raychev
The team

Who we are

We are a team of world-renowned experts and thought leaders in cerebrovascular disease based in Los Angeles, coupled with talented IT and machine learning specialists located in one of the EU's leading IT hubs – Bulgaria. Our unique expertise allows us to lead the way in technological and scientific advancements in acute stroke treatment and diagnosis.
  • Management
  • Technology
  • Clinical
Radoslav Raychev

Radoslav Raychev, MD

CEO & Co-Founder

todor-760x760

Todor Todorov

COO & Co-Founder

May Nour

May Nour, MD

Chief Medical Officer

Atanas Zdravkov

Atanas Zdravkov

Chief Technology Officer

Jeffrey L. Saver

Jeffrey L. Saver, MD

Medical Advisor

David Liebeskind

David Liebeskind, MD

Medical Advisor

Our edge

World’s leading stroke experts

+

Breakthrough ML Expertise

+

Data from real stroke patients

AI model with close to 100% accuracy in detecting stroke symptoms

NeuronicsMedical Contact
Contact

Want to
help?

We are ready to onboard more partners on our life-saving journey. From health tech visionaries and pharmaceutical or insurance companies to neurologists and AI experts, everyone is welcome to support our efforts to reduce the physical, psychological, and financial burden of delayed stroke detection and triage.

Radoslav Raychev

Radoslav Raychev

MD, FAHA, FSVIN
CEO and Co-Founder

Vascular and Interventional Neurologist, Neurointerventional Surgeon and keen researcher in the stroke field. His vision is to have an impact on cerebrovascular disease directly at the bedside with his clinical skills and on a larger scale through research, teaching, and innovative technologies.

Todor Todorov

Todor Todorov

COO and Co-Founder

Serial entrepreneur with multidisciplinary profile of managing startups in verticals ranging from foodtech to digital health. Multiple years of experience as operational head of IT development company tasked with projects from shaping MVPs to bringing large-scale digital products to market

May Nour

May Nour

MD, FAAN, FAHA, FANA, FSVIN
Chief Medical Officer

Graduating from the University of Arizona College of Medicine where she earned her MD degree, Dr. Nour also earned a PhD in neuroscience from the University of Oklahoma Center for Neurosciences. Dually trained at the University of California, Los Angeles (UCLA) as a vascular and interventional neurologist, Dr. Nour helped found the Arline & Henry Gluck Mobile Stroke Rescue Program as its medical director. Under her care, California’s first Mobile Stroke Unit (MSU) began clinical operations in 2017 and continues to operate in Los Angeles County. She has helped advise the startup of multiple national MSUs and has extensive experience in establishment of MSUs and their integration into clinical practice, prehospital medicine and emergency medical systems of care. As the PI, Co-PI and Investigator of multiple clinical trials in the fields of vascular neurology and neurointervention, Dr. Nour has extensive experience in clinical trial design, assessment and outcome analysis. She lends her vast experience and expertise, fueled by her passion to transforming the landscape of neurological care.

Atanas Zdravkov

Atanas Zdravkov

Head of Technology

Experienced and accomplished software engineer with over 20 years of proven success in the industry. Highly skilled in various aspects of software development with expertise in coding across multiple programming languages, requirements analysis and specification, dev-ops, UX design, and agile methodologies.

Svetlin Penkov

Svetlin Penkov

PhD
ML/AI Advisor

Reseacher and entrepreneur with extensive experience in tools for testing and debugging machine learning code that speed up development, save hours of fighting elusive bugs and provide deep theoretical insights. Together with Daniel Angelov, he developed a successful platform for testing ML models.

Daniel Angelov

Daniel Angelov

PhD
ML/AI Advisor

Experienced researcher in AI and robotics field with background in developing ML for medical applications. Together with Dr. Penkov, he works on methods for extracting structured mechanisms and representations from raw data resulting in explainable and robust models.

Jeffrey L. Saver

Jeffrey L. Saver

MD, FAHA, FAAN, FANA
Medical Advisor

SA Vice-Chair and Professor of Neurology at UCLA, and Director of the UCLA Comprehensive Stroke and Vascular Neurology Program. Author of over 670 research articles, 3 books, and 40 book chapters, Dr. Saver’s research interests are in acute stroke treatment, stroke prevention, neuroimaging, clinical trial design, and neurocognitive consequences of stroke.

David Liebeskind

David Liebeskind

MD, FAAN, FAHA, FANA, FSVIN, FWSO
Medical Advisor

Professor of Neurology at the University of California, Los Angeles (UCLA) where he is Director of the UCLA Stroke Center. He is Director of the Neurovascular Imaging Research Core, leading global efforts to advance data science and precision medicine of stroke imaging for prevention, acute therapies and recovery after stroke.